Permanently Discontinued

MAR-GABAPENTIN

MARCAN PHARMACEUTICALS INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is MAR-GABAPENTIN discontinued in Canada?

Yes. The manufacturer has reported to Health Canada that MAR-GABAPENTIN 300MG has been permanently discontinued (last updated February 18, 2020). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.

Can I still get this?Possibly — same-ingredient product records found

StatusPermanently Discontinued

Same-ingredient products on file6 products · 5 same form & route

Affected strength300MG

Report last updated2020-02-18

Checked by MedShort2026-11-12

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

GABAPENTIN

SIVEM PHARMACEUTICALS ULC

300MG · DIN 02246315

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

AURO-GABAPENTIN

AURO PHARMA INC

300MG · DIN 02321211

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

Other Products

PMS-GABAPENTIN

PHARMASCIENCE INC

400MG · DIN 02243448

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

TEVA-GABAPENTIN

TEVA CANADA LIMITED

100MG · DIN 02244513

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

RIVA-GABAPENTIN

LABORATOIRE RIVA INC.

100MG · DIN 02251167

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

AURO-GABAPENTIN TABLETS

AURO PHARMA INC

800MG · DIN 02428342

Different strengthDifferent dosage formSame routeNo current shortage

Compare these two →

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

02391481

Strength

300MG

Dosage Form

CAPSULE

Route

ORAL

Active Ingredient

GABAPENTIN

See all GABAPENTIN products →

Compare with another product →

Product Monograph

Official Product Monograph (Health Canada)

View official Health Canada drug record ↗

Shortage Timeline

Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.

Active/anticipated Resolved

Shortage History

2020-02-18

Active Shortage

Other (Please describe in comments)

Other Products from MARCAN PHARMACEUTICALS INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

ACETAZOLAMIDE FOR INJECTION USP

500MG · DIN 02537893

AMIKACIN SULFATE INJECTION USP

500MG · DIN 02481073

ARSENIC TRIOXIDE FOR INJECTION

1MG · DIN 02554364

BICNU

100MG · DIN 00297763

BICNU

100MG · DIN 02555093

BORTEZOMIB FOR INJECTION

3.5MG · DIN 02493306